Verastem reported $66.79M in Debt for its fiscal quarter ending in September of 2024.





Debt Change Date
AbbVie USD 67.5B 67.5B Dec/2025
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
AstraZeneca USD 33.92B 4.3B Mar/2026
Curis USD 0 0 Jun/2022
Cytokinetics USD 1.29B 4.48M Mar/2026
Gilead Sciences USD 24.94B 5M Dec/2025
Incyte USD 39.43M 982K Mar/2026
Laboratory Of America USD 6.53B 3.9M Dec/2025
Novartis USD 47B 11.62B Mar/2026
Pfizer USD 63.73B 231M Mar/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
TG Therapeutics USD 253.71M 8.37M Dec/2025
Verastem USD 66.79M 26.7M Sep/2024